These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 8965913)

  • 41. Update on Diagnosis and Treatment of Adult Pulmonary Alveolar Proteinosis.
    Iftikhar H; Nair GB; Kumar A
    Ther Clin Risk Manag; 2021; 17():701-710. PubMed ID: 34408422
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhaled Molgramostim Therapy in Autoimmune Pulmonary Alveolar Proteinosis.
    Trapnell BC; Inoue Y; Bonella F; Morgan C; Jouneau S; Bendstrup E; Campo I; Papiris SA; Yamaguchi E; Cetinkaya E; Ilkovich MM; Kramer MR; Veltkamp M; Kreuter M; Baba T; Ganslandt C; Tarnow I; Waterer G; Jouhikainen T;
    N Engl J Med; 2020 Oct; 383(17):1635-1644. PubMed ID: 32897035
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pulmonary alveolarproteinosis in children.
    Bush A; Pabary R
    Breathe (Sheff); 2020 Jun; 16(2):200001. PubMed ID: 32684993
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Therapeutic effect of subcutaneous injection of low dose recombinant human granulocyte-macrophage colony-stimulating factor on pulmonary alveolar proteinosis.
    Zhang F; Weng D; Su Y; Yin C; Shen L; Zhang Y; Zhou Y; Li Q; Hu Y; Li H
    Respir Res; 2020 Jan; 21(1):1. PubMed ID: 31898493
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Whole lung lavage using a rapid infusion system to treat a patient with pulmonary alveolar proteinosis.
    Ra SW; Park SE; Lee HK; Han IS; Park SH
    Yeungnam Univ J Med; 2020 Jan; 37(1):67-72. PubMed ID: 31661750
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gasping for a Diagnosis.
    D'Silva K; Brown S; Hunninghake GM; Vivero M; Loscalzo J
    N Engl J Med; 2019 Mar; 380(10):961-967. PubMed ID: 30855747
    [No Abstract]   [Full Text] [Related]  

  • 47. Better approach for autoimmune pulmonary alveolar proteinosis treatment: inhaled or subcutaneous granulocyte-macrophage colony-stimulating factor: a meta-analyses.
    Sheng G; Chen P; Wei Y; Chu J; Cao X; Zhang HL
    Respir Res; 2018 Aug; 19(1):163. PubMed ID: 30165864
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Potential association between membranous nephropathy and sargramostim therapy for pulmonary alveolar proteinosis.
    Sewaralthahab K; Rennke H; Sewaralthahab S; Madias NE; Jaber BL
    Clin Nephrol Case Stud; 2015; 3():31-36. PubMed ID: 29043131
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Successful Treatment of Autoimmune Pulmonary Alveolar Proteinosis in a Pediatric Patient.
    Trukalj M; Perica M; Ferenčić Ž; Erceg D; Navratil M; Redžepi G; Nogalo B
    Am J Case Rep; 2016 Sep; 17():641-5. PubMed ID: 27592713
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pulmonary Alveolar Proteinosis Syndrome.
    Suzuki T; Trapnell BC
    Clin Chest Med; 2016 Sep; 37(3):431-40. PubMed ID: 27514590
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term follow-up of whole lung lavage in patients with pulmonary alveolar proteinosis.
    Zhou X; Lu G; Yu Z; Gao F; Bian T
    Exp Ther Med; 2014 Sep; 8(3):763-768. PubMed ID: 25120596
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Smallpox inoculation (variolation) in East Africa with special reference to the practice among the Boran and Gabra of Northern Kenya.
    Imperato PJ; Imperato GH
    J Community Health; 2014 Dec; 39(6):1053-62. PubMed ID: 25100176
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-term inhaled granulocyte macrophage-colony-stimulating factor in autoimmune pulmonary alveolar proteinosis: effectiveness, safety, and lowest effective dose.
    Papiris SA; Tsirigotis P; Kolilekas L; Papadaki G; Papaioannou AI; Triantafillidou C; Papaporfyriou A; Karakatsani A; Kagouridis K; Griese M; Manali ED
    Clin Drug Investig; 2014 Aug; 34(8):553-64. PubMed ID: 24890235
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A simplified method for the efficient refolding and purification of recombinant human GM-CSF.
    Thomson CA; Olson M; Jackson LM; Schrader JW
    PLoS One; 2012; 7(11):e49891. PubMed ID: 23166789
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pulmonary alveolar proteinosis and successful therapy with combined lavage procedures: Case reports.
    Firat ND; Cıledağ A; Kabalak PA; Karnak D; Meco BC; Alanoğlu Z; Alkiş N
    Exp Ther Med; 2011 May; 2(3):569-573. PubMed ID: 22977542
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pulmonary alveolar proteinosis: diagnostic and therapeutic challenges.
    Campo I; Kadija Z; Mariani F; Paracchini E; Rodi G; Mojoli F; Braschi A; Luisetti M
    Multidiscip Respir Med; 2012 Jun; 7(1):4. PubMed ID: 22958344
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Whole lung lavage for pulmonary alveolar proteinosis.
    Jayaraman S; Gayathri AR; Senthil Kumar P; Santosham R; Santosham R; Narasimhan R
    Lung India; 2010 Jan; 27(1):33-6. PubMed ID: 20539770
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The molecular basis of pulmonary alveolar proteinosis.
    Carey B; Trapnell BC
    Clin Immunol; 2010 May; 135(2):223-35. PubMed ID: 20338813
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical features and outcomes of idiopathic pulmonary alveolar proteinosis in Korean population.
    Byun MK; Kim DS; Kim YW; Chung MP; Shim JJ; Cha SI; Uh ST; Park CS; Jeong SH; Park YB; Lee HL; Park MS
    J Korean Med Sci; 2010 Mar; 25(3):393-8. PubMed ID: 20191038
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rare lung disease II: pulmonary alveolar proteinosis.
    Juvet SC; Hwang D; Waddell TK; Downey GP
    Can Respir J; 2008; 15(4):203-10. PubMed ID: 18551202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.